Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Immune Tolerance"" wg kryterium: Temat


Tytuł:
Mechanisms underlying immunosuppression by regulatory cells.
Autorzy:
Goldmann O; Infection Immunology Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Nwofor OV; Infection Immunology Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Chen Q; Infection Immunology Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Medina E; Infection Immunology Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 06; Vol. 15, pp. 1328193. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
T-Lymphocytes, Regulatory*
Immune Tolerance*
Cytokines ; Transforming Growth Factor beta ; Immunosuppression Therapy
Czasopismo naukowe
Tytuł:
Heterogeneity and subtypes of CD4 regulatory T cells: implications for tumor therapy.
Autorzy:
Lin H; Department of Otolaryngology, Fujian Institute of Otorhinolaryngology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; National Regional Medical Center, Fujian Medical University, Fuzhou, China.
Xu Y; Department of Otolaryngology, Fujian Institute of Otorhinolaryngology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; National Regional Medical Center, Fujian Medical University, Fuzhou, China.
Lin C; Department of Otolaryngology, Fujian Institute of Otorhinolaryngology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; National Regional Medical Center, Fujian Medical University, Fuzhou, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 05; Vol. 14, pp. 1291796. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
MeSH Terms:
T-Lymphocytes, Regulatory*
Immune Tolerance*
Homeostasis
Czasopismo naukowe
Tytuł:
Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia.
Autorzy:
Luo F; Department of Obstetrics and Gynecology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.; Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, China.; Department of Obstetrics/Gynecology, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.
Liu F; Department of Obstetrics/Gynecology, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.
Guo Y; School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xu W; Department of Obstetrics/Gynecology, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital of Sichuan University, Chengdu, China.
Li Y; Department of Obstetrics and Gynecology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.
Yi J; Department of Obstetrics and Gynecology Nursing, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.
Fournier T; Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre & Postnatal Microbiota, Université Paris Cité, Paris, France.
Degrelle S; Inovarion, Paris, France.
Zitouni H; Laboratory of Human Genome and Multi-factorial Diseases, Faculty of Pharmacy of Monastir, Monastir, Tunisia.
Hernandez I; Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre & Postnatal Microbiota, Université Paris Cité, Paris, France.
Liu X; Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, China.
Huang Y; Department of Obstetrics and Gynecology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.
Yue J; Department of Obstetrics and Gynecology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.; Sichuan Provincial Key Laboratory for Human Disease Gene Study, Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.; School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Oct 03; Vol. 14, pp. 1234577. Date of Electronic Publication: 2023 Oct 03 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Decidua*/immunology
Immune Tolerance*/genetics
Immune Tolerance*/immunology
Pre-Eclampsia*/genetics
Pre-Eclampsia*/immunology
Pre-Eclampsia*/metabolism
Female ; Humans ; Pregnancy ; Killer Cells, Natural ; Placenta/immunology
Czasopismo naukowe
Tytuł:
Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance.
Autorzy:
Dao Nyesiga G; Idogen AB, Lund, Sweden.; Department of Biomedical Sciences, Faculty of Health and Society, Malmö University, Malmö, Sweden.
Pool L; Idogen AB, Lund, Sweden.
Englezou PC; Idogen AB, Lund, Sweden.
Hylander T; Idogen AB, Lund, Sweden.
Ohlsson L; Department of Biomedical Sciences, Faculty of Health and Society, Malmö University, Malmö, Sweden.
Appelgren D; Department of Health, Medicine and Caring Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Sundstedt A; Idogen AB, Lund, Sweden.
Tillerkvist K; Idogen AB, Lund, Sweden.
Romedahl HR; Idogen AB, Lund, Sweden.
Wigren M; Idogen AB, Lund, Sweden.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Oct 13; Vol. 14, pp. 1045183. Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immune Tolerance*
Transforming Growth Factor beta*/metabolism
Humans ; Tretinoin/metabolism ; Dendritic Cells ; Mucous Membrane
Czasopismo naukowe
Tytuł:
Immunological Aspects of Infertility-The Role of KIR Receptors and HLA-C Antigen.
Autorzy:
Wasilewska A; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Grabowska M; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Moskalik-Kierat D; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Brzoza M; Laboratory of Immunogenetics, University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland.
Laudański P; Department of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, 02-091 Warsaw, Poland.; Women's Health Research Institute, Calisia University, 62-800 Kalisz, Poland.; OVIklinika Infertility Center, 01-377 Warsaw, Poland.
Garley M; Department of Immunology, Medical University of Bialystok, 15-269 Białystok, Poland.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Dec 27; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HLA-C Antigens*
Infertility*/immunology
Immune Tolerance*
Female ; Humans ; Pregnancy ; Antigen Presentation ; Germ Cells/immunology
Czasopismo naukowe
Tytuł:
Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer.
Autorzy:
Kandala S; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Ramos M; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Voith von Voithenberg L; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Diaz-Jimenez A; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Chocarro S; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Keding J; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Sotillo R; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Translational Lung Research Center Heidelberg (TRLC), German Center for Lung Research (DZL), Heidelberg, Germany. Electronic address: .
Pokaż więcej
Źródło:
Cell reports [Cell Rep] 2023 Dec 26; Vol. 42 (12), pp. 113266. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Chromosomal Instability*
Breast Neoplasms*/genetics
Breast Neoplasms*/immunology
Immune Tolerance*
Polo-Like Kinase 1*/genetics
Polo-Like Kinase 1*/metabolism
Tumor Escape*
Humans ; Animals ; Mice ; Cell Line, Tumor ; Receptor, ErbB-2/genetics ; NF-kappa B/metabolism ; B7-H1 Antigen/metabolism ; Mannose Receptor/metabolism ; Killer Cells, Natural/immunology ; Heterografts ; MCF-7 Cells ; Female
Czasopismo naukowe
Tytuł:
Draining Lymph Nodes in Human Kidney Pancreas Transplant: Potential Implications in Alloimmunity and Tolerance.
Autorzy:
Nguyen JH; Division of Transplant Surgery, Mayo Clinic, Jacksonville, Florida. Electronic address: .
Pokaż więcej
Źródło:
Transplantation proceedings [Transplant Proc] 2023 Nov; Vol. 55 (9), pp. 2183-2185. Date of Electronic Publication: 2023 Sep 24.
Typ publikacji:
Journal Article
MeSH Terms:
Lymph Nodes*
Immune Tolerance*
Humans ; Transplantation, Homologous ; Pancreas
Czasopismo naukowe
Tytuł:
Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation.
Autorzy:
Wang X; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Sun L; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Yang B; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Li W; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Zhang C; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Yang X; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.; Xi'an Key Laboratory of Immune-Related Diseases, Xi'an, Shannxi, China.
Sun Y; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Shen X; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Gao Y; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Ju B; Department of Rheumatology and Immunology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Gao Y; Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Suzhou Institute of Systems Medicine, Suzhou, China.
Liu D; Department of Rheumatology and Immunology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
Song J; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Jia X; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Su Y; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Jiao A; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Liu H; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Zhang L; Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Suzhou Institute of Systems Medicine, Suzhou, China.
He L; Department of Rheumatology and Immunology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Lei L; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Chen W; Mucosal Immunology Section, National Institute of Dental and Craniofacial Research (NIDCR), NIH, Bethesda, Maryland, USA.
Zhang B; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, China.; Institute of Infection and Immunity, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.; Xi'an Key Laboratory of Immune-Related Diseases, Xi'an, Shannxi, China.; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2023 Oct 16; Vol. 133 (20). Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Immune Tolerance*
T-Lymphocytes, Regulatory*
Animals ; Humans ; Mice ; Autoimmunity ; Fatty Acids/genetics ; Fatty Acids/metabolism ; Mitochondrial Trifunctional Protein, alpha Subunit/metabolism
Czasopismo naukowe
Tytuł:
Reproductive outcomes after pregnancy-induced displacement of preexisting microchimeric cells.
Autorzy:
Shao TY; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Kinder JM; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Harper G; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Pham G; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Peng Y; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Liu J; Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Gregory EJ; Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Sherman BE; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Wu Y; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Iten AE; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Hu YC; Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Russi AE; Division of Gastroenterology, Hepatology and Advanced Nutrition, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Erickson JJ; Division of Neonatology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Miller-Handley H; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.; Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Way SS; Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Sep 22; Vol. 381 (6664), pp. 1324-1330. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Journal Article
MeSH Terms:
Pregnancy*/immunology
Chimerism*
Fetus*/cytology
Fetus*/immunology
Immune Tolerance*
Maternal-Fetal Exchange*/immunology
Immunologic Memory*
Animals ; Female ; Mice ; Antigens/immunology ; Cell Plasticity ; Forkhead Transcription Factors/immunology ; Mice, Inbred C57BL ; T-Lymphocytes, Regulatory/immunology
Czasopismo naukowe
Tytuł:
How mothers tolerate their children.
Autorzy:
Porrett PM; Department of Surgery, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Sep 22; Vol. 381 (6664), pp. 1286. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Journal Article
MeSH Terms:
Immune Tolerance*
Maternal-Fetal Exchange*/immunology
Fetus*/cytology
Fetus*/immunology
Chimerism*
Child ; Female ; Humans ; Pregnancy ; Antigens/immunology
Czasopismo naukowe
Tytuł:
New Insights in Immunometabolism in Neonatal Monocytes and Macrophages in Health and Disease.
Autorzy:
de Jong R; Department of Pediatrics, RWTH Aachen University, 52074 Aachen, Germany.
Tenbrock K; Department of Pediatrics, RWTH Aachen University, 52074 Aachen, Germany.
Ohl K; Department of Pediatrics, RWTH Aachen University, 52074 Aachen, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 16; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Autoimmune Diseases*
Monocytes*
Immune Tolerance*
Adult ; Humans ; Infant, Newborn ; Citric Acid Cycle ; Macrophages
Czasopismo naukowe
Tytuł:
Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Autorzy:
Guo S; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yuan J; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Meng X; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Feng X; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Ma D; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Han Y; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic address: .
Li K; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Sep; Vol. 122, pp. 110601. Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cancer-Associated Fibroblasts*/immunology
Immune Tolerance*
Neoplasms*/immunology
Tumor Microenvironment*
Humans ; Antigen Presentation
Czasopismo naukowe
Tytuł:
Potential role for oral tolerance in gene therapy.
Autorzy:
Butterfield JSS; Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL 32607, United States.
Li X; Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN 46202, United States.
Arisa S; Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN 46202, United States.
Kwon KC; Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Daniell H; Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States. Electronic address: .
Herzog RW; Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN 46202, United States. Electronic address: .
Pokaż więcej
Źródło:
Cellular immunology [Cell Immunol] 2023 Sep-Oct; Vol. 391-392, pp. 104742. Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Immune Tolerance*
Hemophilia A*/genetics
Hemophilia A*/therapy
Mice ; Animals ; Genetic Therapy ; Factor VIII/genetics ; Antigens ; Antibodies
Czasopismo naukowe
Tytuł:
Foxp3 regulatory T cells in the central nervous system and other nonlymphoid tissues.
Autorzy:
Korn T; Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine, Munich, Germany.; Department of Neurology, Technical University of Munich School of Medicine, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Pokaż więcej
Źródło:
European journal of immunology [Eur J Immunol] 2023 Aug; Vol. 53 (8), pp. e2250227. Date of Electronic Publication: 2023 May 14.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Regulatory*
Immune Tolerance*
Lymphoid Tissue ; Self Tolerance ; Transcription Factors ; Central Nervous System ; Forkhead Transcription Factors
Czasopismo naukowe
Tytuł:
Regulatory T-cell dysfunction and its implication for cell therapy.
Autorzy:
Valentini N; Medicine Department, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.; Microbiology, Infectiology and Immunology Department, Université de Montréal, Montreal, QC, Canada.
Requejo Cier CJ; Medicine Department, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.; Microbiology, Infectiology and Immunology Department, Université de Montréal, Montreal, QC, Canada.
Lamarche C; Medicine Department, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.; Medicine Department, Université de Montréal, Montreal, QC, Canada.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2023 Jul 05; Vol. 213 (1), pp. 40-49.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes, Regulatory*
Immune Tolerance*
CD4-Positive T-Lymphocytes/metabolism ; Immunotherapy, Adoptive ; Cell- and Tissue-Based Therapy ; Forkhead Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens.
Autorzy:
Damo M; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Hornick NI; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
Venkat A; Departments of Genetics and of Computer Science, Yale University School of Medicine, New Haven, CT, USA.
William I; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Clulo K; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Venkatesan S; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
He J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Fagerberg E; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Loza JL; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Kwok D; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Tal A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Buck J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Cui C; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Singh J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Damsky WE; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Leventhal JS; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
Krishnaswamy S; Departments of Genetics and of Computer Science, Yale University School of Medicine, New Haven, CT, USA.
Joshi NS; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jul; Vol. 619 (7968), pp. 151-159. Date of Electronic Publication: 2023 Jun 21.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens*/immunology
CD8-Positive T-Lymphocytes*/cytology
CD8-Positive T-Lymphocytes*/immunology
CD8-Positive T-Lymphocytes*/metabolism
CD8-Positive T-Lymphocytes*/pathology
Immune Tolerance*
Programmed Cell Death 1 Receptor*/immunology
Programmed Cell Death 1 Receptor*/metabolism
Skin*/cytology
Skin*/immunology
Skin*/metabolism
Skin*/pathology
Animals ; Humans ; Mice ; Biopsy ; Epidermis/immunology ; Epidermis/metabolism ; Gene Expression Profiling ; Lichen Planus/immunology ; Lichen Planus/pathology
Czasopismo naukowe
Tytuł:
Towards a quantitative theory of tolerance.
Autorzy:
Mora T; Laboratoire de Physique de l'Ecole Normale Supérieure, Centre National de la Recherche Scientifique (CNRS), Université Paris Sciences et Lettres (PSL University), Sorbonne Université, and Université Paris-Cité, 75005 Paris, France. Electronic address: .
Walczak AM; Laboratoire de Physique de l'Ecole Normale Supérieure, Centre National de la Recherche Scientifique (CNRS), Université Paris Sciences et Lettres (PSL University), Sorbonne Université, and Université Paris-Cité, 75005 Paris, France. Electronic address: .
Pokaż więcej
Źródło:
Trends in immunology [Trends Immunol] 2023 Jul; Vol. 44 (7), pp. 512-518. Date of Electronic Publication: 2023 May 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
T-Lymphocytes*
Immune Tolerance*
Humans ; Thymus Gland ; Receptors, Antigen, T-Cell/genetics ; Autoimmunity ; Self Tolerance
Czasopismo naukowe
Tytuł:
Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches.
Autorzy:
Giardino G; Pediatric Section, Department of Translational Medical Sciences, Federico II University, Naples, Italy. Electronic address: .
Romano R; Pediatric Section, Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Lougaris V; Department of Clinical and Experimental Sciences, Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, University of Brescia and ASST-Spedali Civili di Brescia, Brescia, Italy.
Castagnoli R; Department of Pediatrics, Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Cillo F; Pediatric Section, Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Leonardi L; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
La Torre F; Department of Pediatrics, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy.
Soresina A; Unit of Pediatric Immunology, Pediatrics Clinic, University of Brescia, ASST Spedali Civili Brescia, Brescia, Italy.
Federici S; Division of Rheumatology, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Cancrini C; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; Research Unit of Primary Immunodeficiencies, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Pacillo L; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; Research Unit of Primary Immunodeficiencies, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Toriello E; Pediatric Section, Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Cinicola BL; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Corrente S; Division of Pediatrics, S. Camillo-Forlanini Hospital, Rome, Italy.
Volpi S; Center for Autoinflammatory Diseases and Immunodeficiency, IRCCS Istituto Giannina Gaslini, Università degli Studi di Genova, Genoa, Italy.
Marseglia GL; Department of Pediatrics, Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Pignata C; Pediatric Section, Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Cardinale F; Department of Pediatrics, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy.
Pokaż więcej
Corporate Authors:
Immunology Task Force of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Źródło:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2023 Jun; Vol. 251, pp. 109302. Date of Electronic Publication: 2023 Mar 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immune Tolerance*
Immune System Diseases*/genetics
Immune System Diseases*/therapy
Humans
Czasopismo naukowe
Tytuł:
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Autorzy:
Fidelle M; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Rauber C; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Department of Gastroenterology and Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Alves Costa Silva C; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Tian AL; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Lahmar I; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
de La Varende AM; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Zhao L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Thelemaque C; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Lebhar I; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Messaoudene M; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Pizzato E; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Birebent R; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Mbogning Fonkou MD; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Zoppi S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Reni A; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
Dalban C; Clinical Research Department, Centre Léon Bérard, Lyon, France.
Leduc M; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Ferrere G; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; EverImmune, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Durand S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Ly P; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.
Silvin A; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Mulder K; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Dutertre CA; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Ginhoux F; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Yonekura S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Roberti MP; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany.
Tidjani-Alou M; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Terrisse S; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Chen J; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Kepp O; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
Schippers A; Department of Pediatrics, University Hospital RWTH Aachen, Aachen, Germany.
Wagner N; Department of Pediatrics, University Hospital RWTH Aachen, Aachen, Germany.
Suárez-Gosálvez J; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
Fahrner JE; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Richard C; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Bosq J; JBO Consultant, Paris, France.
Lordello L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.
Vitali G; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Galleron N; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Quinquis B; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Le Chatelier E; MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
Blanchard L; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Girard JP; Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.
Jarry A; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
Gervois N; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
Godefroy E; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
Labarrière N; Nantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.; LabEx IGO, Université de Nantes, Nantes, France.
Koschny R; Department of Gastroenterology and Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Daillère R; EverImmune, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Besse B; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
Truntzer C; Université de Bourgogne Franche-Comté, Plateforme de Transfert de Biologie du Cancer, Centre Georges-François Leclerc, Equipe Labellisée Ligue Nationale Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Institut Médical de Génétique et d'Immunologie, Dijon, France.
Ghiringhelli F; Université de Bourgogne Franche-Comté, Plateforme de Transfert de Biologie du Cancer, Centre Georges-François Leclerc, Equipe Labellisée Ligue Nationale Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Institut Médical de Génétique et d'Immunologie, Dijon, France.
Coatnoan N; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.; Sorbonne Université, INSERM, UMRS959 Immunology-Immunopathology-Immunotherapy Laboratory, Paris, France.
Mhanna V; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.; Sorbonne Université, INSERM, UMRS959 Immunology-Immunopathology-Immunotherapy Laboratory, Paris, France.
Klatzmann D; AP-HP, Hôpital Pitié-Salpêtrière, Clinical Investigation Center for Biotherapies (CIC-BTi) and Immunology-Inflammation-Infectiology and Dermatology Department (3iD), Paris, France.; Sorbonne Université, INSERM, UMRS959 Immunology-Immunopathology-Immunotherapy Laboratory, Paris, France.
Drubay D; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Office of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France.
Albiges L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.
Thomas AM; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.
Segata N; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.; Istituto Europeo di Oncologia (IEO), National Cancer Institute (IRCCS), Milan, Italy.
Danlos FX; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Marabelle A; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif Cedex, France.
Routy B; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada.
Derosa L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.
Kroemer G; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Zitvogel L; Gustave Roussy Cancer Campus, Villejuif Cedex, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Jun 09; Vol. 380 (6649), pp. eabo2296. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/adverse effects
Cell Adhesion Molecules*/metabolism
Drug Resistance, Neoplasm*
Gastrointestinal Microbiome*/immunology
Immune Checkpoint Inhibitors*/therapeutic use
Immune Tolerance*/drug effects
Immunologic Surveillance*
Integrins*/metabolism
Mucoproteins*/metabolism
Neoplasms*/immunology
Neoplasms*/therapy
Animals ; Humans ; Mice ; Bacteria/immunology ; Cell Movement ; Fecal Microbiota Transplantation ; Interleukin-17/metabolism ; Th17 Cells/immunology ; Gastrointestinal Tract/immunology ; Gastrointestinal Tract/microbiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies